Westat is committed to continuing the trusted partnership with NIH/NIDA and FDA/CTP on the Population Assessment of Tobacco and Health (PATH) Study to understand tobacco use patterns and impacts on ...

Bio-Path Holdings, Inc. BPTH announced that it has completed the second dose cohort in the dose-escalation portion of an early-stage study evaluating its investigational candidate, BP1002, for the ...

Patients who choose not to intervene after a diagnosis of thyroid cancer face a challenging path--one that is often defined by a sense of isolation and anxiety, according to a first-of-its-kind study ...